Researchers show that using a tumor’s own bacteria is a promising anticancer therapy

Cancer remains one of the leading causes of death worldwide. Researchers are constantly looking for new therapies with improved anticancer activity, fewer side effects, and lower costs. In recent years, interest in bacterial agents as anticancer therapeutics has grown, due to the ability of some bacteria to selectively grow inside hypoxic tumors, i.e., these cells do not receive rich oxygen supply.

Study sheds light on how patients with rare, severe immunodeficiency are still able to defend themselves

The first study of humans with a rare immunodeficiency reveals how the immune system protects the body against pathogens known to cause serious diseases, such as tuberculosis and COVID-19. The research involving McGill University, paves the way for new therapies to treat autoimmune diseases, chronic inflammatory diseases, and new approaches to vaccine development.

Replaying outcomes in the brain could predict whether we approach or avoid situations

Past neuroscience studies suggest that when deciding their next actions, mice and other rodents tend to replay past outcomes of similar situations in their brain, which is reflected in a rapid activation of certain brain regions in a sequence. Recently, some studies recorded similar replay-associated brain activity in the human brain using imaging techniques.

AI predicts future pancreatic cancer

An artificial intelligence tool has successfully identified people at the highest risk for pancreatic cancer up to three years before diagnosis using solely the patients’ medical records, according to new research led by investigators at Harvard Medical School and the University of Copenhagen, in collaboration with VA Boston Healthcare System, Dana-Farber Cancer Institute, and the Harvard T.H. Chan School of Public Health.

Study sheds light on the mysterious evolution of DNA rings in tumors

Tumors sometimes seem to take on a life of their own, growing at an unusually fast rate or suddenly developing resistance to a cancer drug. This behavior is often explained by cancer genes separating from the cell’s own chromosomes and “striking out on their own” in ring shapes. So far, little has been known about how exactly these DNA rings arise and how they continue to develop as the tumor grows.